Research output per year
Research output per year
Personal profile
Research interests
I have a specific clinical interest in myeloproliferative neoplasms such as CML, PV, ET, and myelofibrosis.
My research interests primarily focus on conducting clinical research in the development of novel therapies for the treatment of MPNs such as myelofibrosis. I am currently working in collaboration with Dr. Stephen Oh and his lab.
Clinical interests
Myeloproliferative neoplasms, anemia, cytopenias, leukocytosis, myelofibrosis, essential thrombocythemia, and polycythemia vera
Fingerprint
Dive into the research topics where Amy Zhou is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A phase I trial of pevonedistat in combination with ruxolitinib for the treatment of myelofibrosis
Kong, T., Gaudin, N., Gordon, K., Cox, M. J., Zhou, A. & Oh, S. T., Jan 1 2024, In: Therapeutic Advances in Hematology. 15Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Hematopoietic stem cell mobilization for allogeneic stem cell transplantation by motixafortide, a novel CXCR4 inhibitor
Crees, Z. D., Rettig, M. P., Bashey, A., Devine, S. M., Jaglowski, S., Wan, F., Zhou, A., Harding, M., Vainstein-Haras, A., Sorani, E., Gliko-Kabir, I., Grossman, B. J., Westervelt, P., DiPersio, J. F. & Uy, G. L., Sep 26 2023, In: Blood Advances. 7, 18, p. 5210-5214 5 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Hepcidin is elevated in primary and secondary myelofibrosis and remains elevated in patients treated with ruxolitinib
Zhou, A., Kong, T., Fowles, J. S., Jung, C. L., Allen, M. J., Fisher, D. A. C., Fulbright, M., Nemeth, E., Ganz, T. & Oh, S. T., May 2022, In: British Journal of Haematology. 197, 4, p. e49-e52Research output: Contribution to journal › Letter › peer-review
Open Access11 Scopus citations -
Roxadustat for the treatment of anemia in patients with lower-risk myelodysplastic syndrome: Open-label, dose-selection, lead-in stage of a phase 3 study
Henry, D. H., Glaspy, J., Harrup, R., Mittelman, M., Zhou, A., Carraway, H. E., Bradley, C., Saha, G., Modelska, K., Bartels, P., Leong, R. & Yu, K. H. P., Feb 1 2022, In: American journal of hematology. 97, 2, p. 174-184 11 p.Research output: Contribution to journal › Article › peer-review
Open Access38 Scopus citations -
Inflammatory Pathophysiology as a Contributor to Myeloproliferative Neoplasms
Fisher, D. A. C., Fowles, J. S., Zhou, A. & Oh, S. T., Jun 1 2021, In: Frontiers in immunology. 12, 683401.Research output: Contribution to journal › Review article › peer-review
Open Access61 Scopus citations